Exact Sciences expanding cancer diagnostics capabilities with $190M acquisition
Home » Archive » Exact Sciences expanding cancer diagnostics capabilities with $190M acquisition
Exact Sciences
Exact Sciences says the $190 million acquisition of Marshfield-based PreventionGenetics will expand its cancer diagnostics capabilities.
The move also sets up the Madison company’s entrance into the field of hereditary cancer testing, which focuses on detecting heritable genetic mutations that could increase the risk of developing certain cancers.
"With our deep relationships in primary c...
Please log in to access subscriber content.
If you don't have a subscription, please contact schmies@wispolitics.com for subscription options on the WisPolitics-State Affairs platform, which is the new home for WisPolitics subscriber products.
